{"id":"W2778275419","doi":"10.1016/s2352-3026(17)30237-5","title":"Momelotinib versus best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): a randomised, open-label, phase 3 trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":315,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Internal medicine; Clinical endpoint; Anemia; Clinical trial; Phases of clinical research; Intention-to-treat analysis; Janus kinase inhibitor; Surgery; Gastroenterology; Janus kinase; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001587702,0.001657996,0.00309787,0.0004467625,0.0003580415,0.001518318,0.0008479313,0.001745351,0.006390613],"category_scores_gemma":[0.001640899,0.000655961,0.002737897,0.0003731261,0.001021381,0.001562802,0.0004888111,0.003607293,0.0009068849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008001777,"about_ca_system_score_gemma":0.0006784083,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007816933,"about_ca_topic_score_gemma":0.002028906,"domain_scores_codex":[0.9995278,0.0002391918,0.00002379249,0.00008154111,0.00002912089,0.00009857144],"domain_scores_gemma":[0.9992963,0.0002335213,0.0001586992,0.00005131686,0.00002844338,0.0002316636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.974261,0.003312133,0.0006523333,0.000614606,0.001366941,0.00006547668,0.00006303386,0.0005265172,0.001723829,0.0001633532,0.001122891,0.01612776],"study_design_scores_gemma":[0.9596503,0.03692839,0.001382539,0.0000367392,0.0005024286,0.00005322251,0.00002648829,0.0003963916,0.0001906527,0.0001968607,0.00062021,0.00001564218],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9805841,0.01041755,0.000597928,0.001582874,0.0007873816,0.001539067,0.001137059,0.0001786206,0.003175473],"genre_scores_gemma":[0.9877487,0.003718891,0.0009906972,0.001388127,0.0006138676,0.00130095,0.001227731,0.00002902499,0.002982104],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006390613,"threshold_uncertainty_score":0.0213787,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1158773631277653,"score_gpt":0.3732386234299219,"score_spread":0.2573612603021566,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}